Safety evaluation of cleansing foam or facial sunscreen for atopic dermatitis patients

Shiba Palace Clinic0 个研究点目标入组 24 人开始时间: 2016年2月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Japanese females aged from 20 to 50 years old at the time informed consent was provided
•2)Patients with mild to moderate atopic dermatitis
•3)Patients who provided written informed consent to change from their everyday use of cleanser or facial sunscreen to the test agent during the study period

•?Patients with severe or greater atopic dermatitis
•?Patients receiving systemic administration of a drug for a purpose other than atopic dermatitis therapy
•?Patients receiving a topically administered drug on the face for a purpose other than atopic dermatitis therapy
•?Pregnant women, those who may be pregnant, lactating women, or women who hope to become pregnant during the study period
•?Patients for whom the test agent is contraindicated
•?Patients who were considered inappropriate for the study by an investigator

发起方